Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie N M Wong

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
JCO Global Oncology|May 20, 2022
Yuan FenAnnie N M Wong
The Journal of Liquid Biopsy|January 16, 2026
General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancerDanyon Lo, Jenny Wong, Rawiri Keenan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2017
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and ImmunotherapyAnnie N M Wong, Grant A McArthur, Michael S Hofman, et al.
The New Zealand Medical Journal|June 26, 2025
Pembrolizumab-related toxicity in patients with advanced melanomaFlorence de Roo, Amritpreet Singh, Eric Zheng, et al.
JCO Oncology Practice|July 25, 2024
Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New ZealandNiamh Walsh, Rosalie Stephens, Alvin Tan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
JCO Global Oncology|May 20, 2022
Yuan FenAnnie N M Wong
The Journal of Liquid Biopsy|January 16, 2026
General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancerDanyon Lo, Jenny Wong, Rawiri Keenan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 9, 2017
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and ImmunotherapyAnnie N M Wong, Grant A McArthur, Michael S Hofman, et al.
The New Zealand Medical Journal|June 26, 2025
Pembrolizumab-related toxicity in patients with advanced melanomaFlorence de Roo, Amritpreet Singh, Eric Zheng, et al.
JCO Oncology Practice|July 25, 2024
Real-World Outcomes of Immunotherapy for Melanoma Brain Metastases in New ZealandNiamh Walsh, Rosalie Stephens, Alvin Tan, et al.
Pageof 1